Renuvion Safely and Effectively Treats Lax Skin in Trial
In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.
In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.
BTL’s Emface device treats facial skin for wrinkles and increases muscle tone simultaneously without the need for injections or needles.
Physician Speaker Series is a treasure trove of expert knowledge and insights in the field of plastic surgery. To delve deeper into this wealth of wisdom and stay abreast of the latest advancements